Edobacomab
Edobacomab
Edobacomab (pronounced as e-doh-ba-co-mab) is a monoclonal antibody designed for the treatment of certain types of cancer. It is a type of immunotherapy that targets and destroys cancer cells.
Etymology
The term "Edobacomab" is derived from the International Nonproprietary Names (INN), where "edo" refers to the place of origin, "ba" indicates the target, "co" indicates the role of the drug, and "mab" is a suffix used for monoclonal antibodies.
Usage
Edobacomab is used in the treatment of certain types of cancer, including colorectal cancer and non-small cell lung cancer. It works by binding to a specific protein found on the surface of cancer cells, thereby triggering an immune response that destroys the cancer cells.
Related Terms
- Monoclonal Antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Immunotherapy: A type of cancer treatment that helps your immune system fight cancer.
- Colorectal Cancer: A cancer that starts in the colon or the rectum.
- Non-Small Cell Lung Cancer: The most common type of lung cancer.
External links
- Medical encyclopedia article on Edobacomab
- Wikipedia's article - Edobacomab
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski